IPACK Block After Total Knee Arthroplasty
Knee Arthropathy, Postoperative Pain
About this trial
This is an interventional treatment trial for Knee Arthropathy focused on measuring knee arthoplasty, nerve block, analgesia
Eligibility Criteria
Inclusion Criteria:
- primary total knee arthroplasty under spinal anesthesia
Exclusion Criteria:
- Contraindication or refusal to regional anesthesia
- Contraindication to non steroidal anti inflammatory (NSAID's)
- Allergy to opioids
- Allergy to paracetamol
- Creatinine clearance < 30ml/min
- Weight<50 kg or >100kg
Sites / Locations
- Institut Kassab D'OrthopedieRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Canal adductor block
IPACK block
ACB was done in the immediate postoperative period under a high-frequency ultrasound guidance in which the adductor canal was identified beneath the sartorius muscle and 20 ml of 0.2% ropivacaine was injected in the canal using a 22-gauge 100-mm short-beveled regional block needle and a catheter was kept for 48H with 4 ml/h ropivacaine 0.2%.
IPACK was realized after spinal anesthesia. Patient was placed in a supine position and knee placed in position of 90° flexion. A low-frequency ultrasound probe was positioned in the popliteal crease, and the needle was inserted from medial aspect of the knee from anteromedial to posterolateral direction in a plane between the popliteal artery and the femur. The tip of the needle was placed 1-2 cm beyond the lateral edge of the artery, and 20 ml of 0.2% ropivacaine was injected for each side. A ACB was done postoperatively with 20 ml ropivacaine 0.2% and a catheter was kept for 48H with 4 ml/h saline